PMID: 7033844Jan 1, 1981Paper

Nicotine binding sites and their localization in the central nervous system

Neuroscience and Biobehavioral Reviews
B R Martin, M D Aceto

Abstract

The resolution of racemic nicotine to provide optically pure (+)-nicotine and the synthesis of radiolabeled nicotine with high specific activity have facilitated the study of nicotine binding in brain. The actions of the stereoisomers of nicotine on the central nervous system are qualitatively similar in most tests but (-)-nicotine is more potent than the unnatural (+)-isomer by 10-fold or greater. Binding of radiolabeled nicotine to brain has both saturable and nonsaturable components. Only saturable binding is affected by incubation conditions such as time, temperature, pH and ion concentration. Excess concentrations of the stereoisomers are equally effective in displacing (-)-[3H]-nicotine from brain homogenates. Nevertheless, a direct comparison of (+)-[3H]-nicotine and (-)-[3H]-nicotine binding shows that the latter has a KD three times lower than the former. (-)-[3H]-Nicotine is bound to the greatest degree in hypothalamus and hippocampus, areas that also exhibited the most stereoselectivity for nicotine. However, differences in the binding affinities of the two isomers were far less than the pharmacological stereospecificity observed.

References

Feb 1, 1979·Journal of Medicinal Chemistry·M D AcetoW C Vincek
Aug 1, 1979·European Journal of Pharmacology·J S AguilarE De Robertis
Jan 1, 1978·Toxicon : Official Journal of the International Society on Toxinology·N SchechterJ Schmidt
Jul 21, 1977·Biochimica Et Biophysica Acta·W M Moore, R N Brady
Sep 23, 1977·Brain Research·B J MorleyR J Bradley
Aug 24, 1976·Biochimica Et Biophysica Acta·W M Moore, R N Brady
Apr 1, 1975·Toxicology and Applied Pharmacology·A TsujimotoY Kurogochi
Aug 1, 1967·Brain Research·J W Phillis, D H York
Sep 5, 1974·Biochimica Et Biophysica Acta·V A Eterović, E L Bennett
Mar 24, 1972·Biochemical and Biophysical Research Communications·W J Moore, N J Loy
Nov 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·J P ChangeuxC Y Lee
Jan 1, 1966·Experimental Brain Research·D R Curtis, R W Ryall
Jan 1, 1980·Psychopharmacology·L T MeltzerL S Harris
Aug 1, 1980·Journal of Medicinal Chemistry·W C VincekE R Bowman
Jan 1, 1976·Notes and Records of the Royal Society of London·J Eccles
Jun 3, 1961·Nature·H MCKENNISL B TURNBULL
Nov 1, 1962·Acta Physiologica Scandinavica·L E APPELGRENC G SCHMITERLOW
Aug 1, 1965·British Journal of Pharmacology and Chemotherapy·R B Barlow, J T Hamilton
Mar 1, 1947·The Australian Journal of Experimental Biology and Medical Science·C S HICKS, D A SINCLAIR

❮ Previous
Next ❯

Citations

Feb 1, 1991·Naunyn-Schmiedeberg's Archives of Pharmacology·J R CopelandA Nordberg
Jan 1, 1990·Journal of Neural Transmission. General Section·M K Christensen, D F Smith
Jan 1, 1990·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·A NordbergB Långström
Jun 1, 1984·Pharmacology, Biochemistry, and Behavior·J W SloanW R Martin
Nov 1, 1989·Pharmacology, Biochemistry, and Behavior·J W SloanM Bostwick
May 1, 1993·Pharmacology, Biochemistry, and Behavior·M OhnoS Watanabe
Jan 1, 1987·Pharmacology & Therapeutics·R A Wise
Mar 7, 2001·Biological Psychiatry·A H Rezvani, E D Levin
Sep 1, 1987·Behavioral and Neural Biology·E D LevinG D Ellison
Jan 30, 2002·British Journal of Pharmacology·Emmanuel ValjentRafael Maldonado
Jun 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·L G AboodS Grassi
Nov 1, 1988·The Journal of Pharmacy and Pharmacology·J A Scimeca, B R Martin
May 1, 1988·Journal of Pharmaceutical Sciences·P JacobE J Cone
Mar 3, 2009·Journal of Psychopharmacology·K A BrennanP Truman
Mar 14, 2007·The Journal of Pharmacology and Experimental Therapeutics·Marcello SolinasSteven R Goldberg
Jan 1, 1992·British Journal of Haematology·C A Hall
Mar 30, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Kaveri AroraEdward V Quadros
May 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·E H Reynolds
Jan 1, 1987·Journal of Neural Transmission·C LarssonA Nordberg
Nov 19, 2004·The European Journal of Neuroscience·Graciela N BalerioRafael Maldonado

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.